Progress of fundamental research in Wilms' tumor

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Urological research

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00942090PMID 9286029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of Wilms' tumor

  2004cited by this paper
• Autocrine Regulation of Growth by Insulin-Like Growth Factor (IGF)-II Mediated by Type I IGF-Receptor in Wilms Tumor Cells

  1996cited by this paper
• Relationship between p53 status and radiosensitivity in human tumour cell lines.

  1996cited by this paper
• Development of seven new human prostate tumor xenograft models and their histopathological characterization.

  1996cited by this paper
• Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.

  1996cited by this paper
• Heritable nephroblastoma (Wilms' tumor) in the Upjohn Sprague Dawley rat.

  1996cited by this paper
• Heritable nephroblastoma (Wilms' tumor) in the Upjohn Sprague Dawley rat.

  1996cited by this paper
• Immunohistochemical expression of p53 proteins in Wilms’ tumour: a possible association with the histological prognostic parameter of anaplasia

  1996cited by this paper
• Growth factors in renal development.

  1995cited by this paper
• Mutations of p53 in Wilms' tumors.

  1995cited by this paper
• Growth factors in renal development.

  1995cited by this paper
• Apoptosis, cancer and the p53 tumour suppressor gene

  1995cited by this paper
• Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.

  1995cited by this paper
• Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor.

  1995cited by this paper
• Desmin‐related neuromuscular disorders

  1995cited by this paper
• Murine models of neoplasia: functional analysis of the tumour suppressor genesRb-1 andp53

  1995cited by this paper
• Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys.

  1994cited by this paper
• Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma.

  1994cited by this paper
• Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

  1994cited by this paper
• Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.

  1994cited by this paper
• Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors.

  1994cited by this paper
• [Growth factors and cancer].

  1994cited by this paper
• Renal Pathology with Clinical and Functional Correlations

  1994cited by this paper
• Diverse roles of insulin-like growth factors in pediatric solid tumors.

  1994cited by this paper
• Assessment of proliferative activity in Wilms' tumour.

  1994cited by this paper
• Expression of proliferating cell nuclear antigen in Wilms' tumors and other pediatric renal tumors: The correlation between histologic classification and proliferative activity

  1994cited by this paper
• Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.

  1994influential reference
• P-glycoprotein status of favorable-histology Wilms' tumor predicts treatment outcome.

  1994cited by this paper
• An Immunohistochemical Study Comparing Clear Cell Sarcoma Of The Kidney And Wilms' Tumor

  1993influential reference
• Differential expression of neurotrophin receptors during renal development.

  1993cited by this paper
• Applied immunohistochemistry for the surgical pathologist

  1993cited by this paper
• Systemic effects of insulin-like growth factor-II produced and released from Wilms tumour tissue

  1993cited by this paper
• The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.

  1993cited by this paper
• Induction of mouse tenascin expression by a human sarcomatoid wilms' tumor cell line growing in nude mice

  1993cited by this paper
• Morphology and growth characteristics of epithelial cells from classic Wilms' tumors.

  1993influential reference
• A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.

  1993cited by this paper
• Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors

  1993cited by this paper
• Immunohistochemistry of childhood sarcomas: old and new markers.

  1993cited by this paper
• trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues.

  1993cited by this paper
• Isolation of Subclones with Different Tumorigenicity and Metastatic Ability from Rat Nephroblastoma Cell Line, ENUT

  1992cited by this paper
• IGF binding proteins: regulation of cellular actions.

  1992cited by this paper
• A third Wilms' tumor locus on chromosome 16q.

  1992cited by this paper
• Structural aspects of the IGFBP family.

  1992cited by this paper
• Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.

  1992cited by this paper
• Nephrogenic Adenofibroma: A Novel Kidney Tumor of Young People

  1992cited by this paper
• Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours

  1992cited by this paper
• Cytogenetics and molecular genetics of Wilms' tumor of childhood.

  1992cited by this paper
• RNA expression of the WT1 gene in Wilms' tumors in relation to histology.

  1992cited by this paper
• Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and in vivo.

  1991cited by this paper
• Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

  1991cited by this paper
• Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.

  1991cited by this paper
• Correlation of the inability to sustain growth in defined serum‐free medium with the suppression of tumorigenicity in Wilms' nephroblastoma

  1991cited by this paper
• How curable is relapsed Wilms' tumour?

  1991cited by this paper
• Insulin-like growth factor production by childhood solid tumors.

  1991cited by this paper
• Immunohistochemistry on needle biopsies of childhood malignancies.

  1991cited by this paper
• Immunohistochemical demonstration of epidermal growth factor in human gastric cancer xenografts of nude mice

  1990cited by this paper
• Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.

  1990cited by this paper
• Wilms' tumour as a paradigm for the relationship of cancer to development.

  1990cited by this paper
• A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product.

  1990cited by this paper
• Cell differentiation in Wilms' tumor (nephroblastoma): an immunohistochemical study.

  1990cited by this paper
• How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group.

  1990cited by this paper
• Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells

  1989influential reference
• Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells

  1989cited by this paper
• Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.

  1989cited by this paper
• Treatment of Wilms' tumor. Results of the third national Wilms' tumor study

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study.

  1989cited by this paper
• The treatment of Wilms' tumor: an update.

  1989cited by this paper
• Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11

  1988cited by this paper
• Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours

  1988cited by this paper
• Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors.

  1988cited by this paper
• A monoclonal antibody stains blastemal but not tubular components of Wilms' tumour

  1988cited by this paper
• Lack of linkage of familial Wilms' tumour to chromosomal band 11 p13

  1988cited by this paper
• Growth characteristics of human Wilms' tumor in nude mice.

  1988influential reference
• Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.

  1988cited by this paper
• Wilms tumor: past, present, future.

  1988cited by this paper
• Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.

  1987cited by this paper
• The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.

  1987cited by this paper
• Production of platelet‐derived growth factor by cultured Wilms' tumor cells and fetal kidney cells

  1987cited by this paper
• An analysis of histology and DNA-ploidy in primary wilms tumors and their metastases and a study of the morphological effects of therapy

  1987cited by this paper
• Growth factors and cancer.

  1986cited by this paper
• Anaplastic Wilms' tumor: clinical and pathologic studies.

  1985cited by this paper
• Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues

  1985cited by this paper
• Relationship of histology of Wilms' tumor to growth characteristics of nude mouse heterotransplants.

  1985cited by this paper
• The in vitro growth and characterization of the skeletal muscle component of Wilms' tumor.

  1985cited by this paper
• Expression of insulin-like growth factor-II transcripts in Wilms' tumour

  1985cited by this paper
• Relapsed Wilms' tumor: Factors affecting survival and cure

  1985cited by this paper
• Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours

  1984cited by this paper
• Characteristics of 85 pediatric tumors heterotransplanted into nude mice.

  1983cited by this paper
• Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.

  1983cited by this paper
• The Surgical Treatment of Wilms' Tumor: Results of the National Wilms' Tumor Study

  1978cited by this paper
• Transplantation of human tumors in nude mice.

  1976cited by this paper
• Growth promotion by extracts from Wilms' tumor in vitro

  1971cited by this paper
• Bilateral nephroblastomatosis in a premature infant.

  1961cited by this paper

• Xenograft models for pediatric cancer therapies

  2021cites this paper
• Blastemal NCAM+ALDH1+ Wilms' tumor cancer stem cells correlate with disease progression and poor clinical outcome: A pilot study.

  2019cites this paper
• Evaluation of diagnostic utility of imprint cytology in paediatric renal tumours with special references to Ki 67 proliferative marker

  2018cites this paper
• Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis

  2017cites this paper
• Targeted therapy aimed at cancer stem cells: Wilms’ tumor as an example

  2014cites this paper
• The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

  2012influential citation
• Wilms tumor—a renal stem cell malignancy?

  2011influential citation
• The Epithelial Mesenchymal Transition Process in Wilms Tumor: A Study Based on a Xenograft Model

  2011cites this paper
• Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.

  2011cites this paper
• Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population

  2009cites this paper
• Prognostic markers in nephroblastoma (Wilms' tumor).

  2005cites this paper
• MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma

  2004cites this paper
• Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.

  2003cites this paper
• Derivation and characterization of a Wilms' tumour cell line, WiT 49

  2003cites this paper
• Expression and localization of HGF and met in Wilms' tumours

  2002cites this paper
• Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).

  2002cites this paper
• Renal cancer: cytogenetic and molecular genetic aspects.

  2002cites this paper
• Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.

  2000cites this paper
• Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.

  2000cites this paper
• Bilateral Wilms' tumor: a clinicopathologic review.

  1999cites this paper
• DNA methylation in urological malignancies (review).

  1998cites this paper